FDA approves Merck's Emend injection for nausea

01/30/2008 | CNNMoney

Merck & Co. on Tuesday announced that the FDA has approved its Emend injection for the prevention of chemotherapy-induced nausea. The approval covers the drug's 115-mg dosage for use in combination with other treatments for acute and delayed nausea and vomiting due to cancer chemotherapy. The company also said that the injection can replace the 125-mg oral capsule version of Emend.

View Full Article in:

CNNMoney

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ